Novartis Investigative Site

Indianapolis, Indiana 46202

Use our guide to learn which trials are right for you!

We've found
15 trials
at this facility
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Chronic Spontaneous Urticaria Clinical Trial
A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Osteoporosis Clinical Trial
An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
Status: Enrolling, Phase III
Updated: 9/21/2015
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis Clinical Trial
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hidradenitis Suppurativa Clinical Trial
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Solid Tumours Clinical Trial
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Relapsing Multiple Scelrosis Clinical Trial
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Primary Sjögren's Syndrome Clinical Trial
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials